glp-1 drugs and addiction Hype Or Hope? Latest Research On Receptor Agonists GLP-1 medications get at the

The American Journal of Medicine , 138 (6), 934-940

GLP-1 medications accelerate weight lossoften 1520% body weight over 612 monthswhich intensifies this natural process

Now Pfizers public declaration that its at the end of the beginning in entering the GLP1 market marks a pivotal moment: an established pharma giant is moving from watching a niche revolution to competing for mass adoption

In this complex scenario, the concomitant presence of obesity further increases insulin resistance and exacerbates the clinical presentation of PCOS

Although the FDA approved semaglutide for weight loss in 2021, this medications use in treating type 2 diabetes and heart disease dates back to Ozempics2017 approvalfor reducing the risk of heart attack, stroke, or death in people with type 2 diabetes